Today: 30 June 2026
Browse Category

NASDAQ:EB 17 July 2025

The “HTML of the AI Era”? Microsoft’s NLWeb Aims to Put ChatGPT on Every Website

The “HTML of the AI Era”? Microsoft’s NLWeb Aims to Put ChatGPT on Every Website

Imagine every website you visit could talk back – answering your questions in natural language, like a built-in ChatGPT trained on that site’s content. That’s the bold idea behind NLWeb, an open protocol unveiled by Microsoft at its Build 2025 conference. NLWeb promises to make the internet “conversational” by transforming ordinary websites into AI-powered chat interfaces news.microsoft.com theverge.com. With just a few lines of code, any site or app can deploy a custom chatbot that understands free-form questions and responds with relevant answers drawn from the site’s own data – essentially offering ChatGPT-level search on any website theverge.com theverge.com. Microsoft’s CTO Kevin Scott even likens the underlying technology to the web’s next big paradigm: “kind of like HTTP for agents,” a foundational layer for an emerging “agentic web” of AI applications infoworld.com simform.com. Some are calling NLWeb the “HTML of the AI era,” suggesting it could play a role as pivotal for AI-driven interactions as HTML did for the early World Wide Web news.microsoft.com greyhoundresearch.com. NLWeb is an open-source project designed to simplify the creation of natural language interfaces for websites news.microsoft.com news.microsoft.com. In essence, NLWeb provides a standard protocol for asking a website questions in plain language and getting

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Go toTop